This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (24)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Breast Cancer  • Surgical Oncology  • Diagnosis  • Magnetic Resonance Imaging  • Alert me on articles by topic  Social Bookmarking   What's this?

Karl Y. Bilimoria, MD; Angela Cambic, BA; Nora M. Hansen, MD; Kevin P. Bethke, MD

Arch Surg. 2007;142:441-447.

Hypothesis  Women with newly diagnosed breast cancers may harbor additional ipsilateral or contralateral breast malignancies that are undetected by mammography and ultrasonography. Magnetic resonance imaging (MRI) has demonstrated excellent sensitivity in the detection of breast cancers. However, the impact of routine MRI on the surgical management of new, biopsy-proven breast cancers remains unclear.

Design  Retrospective analysis of a prospective database.

Setting  An academic, tertiary care center in a large metropolitan area.

Patients  A total of 155 women with breast cancer newly diagnosed by mammography, ultrasonography, and needle biopsy underwent preoperative bilateral breast MRI in a single-institution, single-surgeon setting during 1 year.

Main Outcome Measures  Change in surgical management based on breast MRI findings.

Results  The MRI demonstrated 124 additional suspicious lesions in 73 patients. Post-MRI follow-up mammograms or ultrasonograms were required in 65 patients, and 41 patients underwent additional image-guided biopsies. There was a change in surgical management as MRI discovered additional, otherwise undetected malignancies in 36 patients based on radiographic-pathologic correlation. Lumpectomy was converted to mastectomy in 10 patients (8 beneficial), wider excision was performed in 21 patients (10 beneficial), and 5 patients (2 beneficial) underwent contralateral surgery. Larger tumor size was an independent predictor of a beneficial change in surgical management (odds ratio, 1.66; 95% confidence interval, 1.04-2.66).

Conclusions  Breast MRI results in a beneficial change in surgical management in 9.7% of newly diagnosed breast cancers. The detection of additional, otherwise undetected ipsilateral and contralateral breast malignancies with MRI suggests that breast MRI may have a role in the evaluation of new breast cancers.

Author Affiliations: Department of Surgery, Division of Surgical Oncology, Northwestern University, Feinberg School of Medicine, Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management
Brennan et al.
JCO 2009;27:5640-5649.
ABSTRACT | FULL TEXT  

Role of Breast MRI in the Preoperative Evaluation of Patients with Newly Diagnosed Breast Cancer
Schell et al.
Am. J. Roentgenol. 2009;192:1438-1444.
ABSTRACT | FULL TEXT  

Increasing Accuracy of Detection of Breast Cancer with 3-T MRI
Elsamaloty et al.
Am. J. Roentgenol. 2009;192:1142-1148.
ABSTRACT | FULL TEXT  

Overview of the Evidence on MRI-guided Local Staging of Breast Cancer and Effect on Treatment
Houssami
Am Soc Clin Oncol Ed Book 2009;2009:45-50.
ABSTRACT | FULL TEXT  

Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer
Houssami et al.
JCO 2008;26:3248-3258.
ABSTRACT | FULL TEXT  

Who Should Have Breast Magnetic Resonance Imaging Evaluation?
Orel
JCO 2008;26:703-711.
ABSTRACT | FULL TEXT